The delegation of the FSI “SID & GP” took part in the conference “India Pharma 2018”
During February 15-17, 2018, the delegation of the FSI “SID & GP” (Vyacheslav Goryachkin – Head of the Department of Educational Production, Mikhail Morozov – Head of the International Cooperation Department, Anastasia Sokolova – Assistant to the Director) took part in the conference “India Pharma 2018”. The delegation visited the exhibition of manufacturers of medicines and medical products and took part in a closed session on the interaction of foreign regulators and representatives of Indian pharmaceutical industry.
The second day of the conference was opened by the session on the exchange of experience of the best practices of representatives of regulatory agencies and international organizations (WHO, EMA, FDA regional office, COFEPRIS, representatives from Singapore, Ghana, and, of course, the hosts of the conference, India). During this session, the assistant to the director of the FSI “SID & GP”, Anastasia Sokolova, made a presentation on the GMP inspectorate of the Russian Federation, followed by a Q & A session on the assessment of the quality of Indian products imported to the international markets the answer was: “There is always room for improvement. It is necessary to move together towards it, developing both regulatory systems. “In addition to participating in the sessions, the Institute delegation also held B-2-B meetings with representatives of COFEPRIS (United States of Mexico) and CDSCO (Republic of India), defying the main ways of interaction in 2018.
Other materials
- Vladislav Shestakov took part in the BioHabana 2024 Congress
- Registration for GMP Conference 2024 is now open
- Cooperation issues in the pharmaceutical industry and healthcare system were discussed at the Russia-Africa Summit
- International cooperation discussed at the Drug Safety Forum
- Transformation of medical education and training of highly qualified personnel discussed at the Uzbek-Russian Medical Forum